OMV AG/ AT0000743059 /
5/28/2024 10:58:31 PM | Chg. 0.000 | Volume | Bid10:58:31 PM | Ask10:58:31 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
47.040EUR | 0.00% | - Turnover: - |
47.040Bid Size: - | 47.440Ask Size: - | 15.21 bill.EUR | 10.86% | 10.27 |
GlobeNewswire
3/26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
1/16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
9/14/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
10/13/2021
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
euro adhoc
7/28/2021
EANS-Tip Announcement: OMV Aktiengesellschaft / Half-year financial report according to art. 125 par...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/7/2021
EANS-DD: OMV Aktiengesellschaft / Notification concerning transactions by persons performing manager...
euro adhoc
6/2/2021
EANS-Other capital market information: OMV Aktiengesellschaft / Acquisition and/or sale of treasury ...